Long-Term Monitoring and Life with Degenerative Myopia
At a Glance
Degenerative myopia needs lifelong, individualized monitoring because it can raise the risk of abnormal blood-vessel growth, glaucoma, retinal problems, and vision loss. Regular eye exams, imaging, and prompt reporting of new symptoms help protect vision.
Because degenerative myopia is a lifelong condition, management is not about a “one-time” treatment, but about consistent, vigilant monitoring. The goal of surveillance is to catch complications like mCNV or glaucoma early [1][2].
Protecting the “Fellow Eye”
One of the most important aspects of monitoring is paying close attention to your “fellow eye”—the eye that may currently have fewer symptoms. If you have already developed mCNV (abnormal blood vessel growth) in one eye, the other eye is at a significantly higher risk for developing the same condition over time [1].
For example, studies indicate that among patients who already have mCNV in one eye, roughly 25% to 35% will develop it in the fellow eye within 8 to 10 years, varying by study population and follow-up period [3][1]. If your fellow eye already has “plus lesions” like lacquer cracks, your risk of a new leak may be over five times higher than someone without them [3]. Note: Your personal risk profile depends on your specific eye and cannot be calculated from these statistics alone.
The Challenge of Glaucoma Detection
People with degenerative myopia are at a higher risk for glaucoma, a disease that damages the optic nerve [4]. However, diagnosing glaucoma in a myopic eye is notoriously difficult for several reasons:
- Altered Anatomy: The stretching of the eye often “tilts” or “rotates” the optic nerve, making it look abnormal even if it is healthy [5][6].
- Thinning Tissue: Myopic eyes already have thinner nerve fiber layers, which can complicate the interpretation of standard glaucoma OCT scans [7].
- Normal-Tension Glaucoma: Some patients develop glaucomatous optic-nerve damage and visual-field loss even when their measured eye pressure (IOP) remains within the statistically normal range [4].
Because of these challenges, your doctor will look for reproducible change over time rather than a single “bad” test result. It is vital to keep all your scan records so your doctor can compare this year’s images to your baseline from years ago, incorporating nerve examination, visual fields, and pressure [8].
Your Home Monitoring Routine
While your specialist will use advanced imaging, you are the first line of defense for your vision.
The Amsler Grid
The Amsler Grid—a simple grid of straight lines—is a helpful tool for detecting new central distortion.
- Wear your reading glasses and hold the grid at a comfortable reading distance.
- Cover one eye and look at the center dot.
- Note if any lines look wavy, bent, or if any part of the grid is “missing.”
- Repeat with the other eye.
If you notice a new area of distortion (metamorphopsia) or a new dark patch, this is a red flag that requires a prompt call to your retina specialist [9][10].
Limitations: The Amsler grid is only a simple screen for some central distortions. It does not monitor for peripheral tears, glaucoma, or all tractional changes, and it is not a substitute for a dilated examination. Use it only as advised by your clinician.
Living with the Condition
If the structural changes of your myopia lead to permanent vision loss, there are specialized resources available to help you maintain your independence.
- Low-Vision Specialists: These are optometrists or ophthalmologists who specialize in maximizing your “functional” vision using high-powered magnifiers, specialized lighting, or digital aids [11].
- Vision Rehabilitation: Occupational therapists can help you adapt your home or workspace, making it easier to read, cook, and navigate safely despite “blind spots” or reduced clarity.
Individualized Surveillance Schedule
Your follow-up intervals will be customized based on your specific lesions, prior history of mCNV, glaucoma risk, symptoms, and treatment status. A sample monitoring plan for a stable patient might include:
- Comprehensive Dilated Exam: To check the peripheral retina for tears or holes [12].
- Macular OCT: To monitor for MTM (splitting layers) or early fluid [13][14].
- Visual Field Testing: Periodic tests (like 10-2 or 24-2 fields) to monitor for glaucoma or central blind spots [15].
- Axial Length Checks: Periodically to see if the eyeball is elongating, although this is not always repeated at every visit [16].
Consistency is your best protection. However, a normal scheduled test or a normal home check does not override new emergency symptoms. If you experience sudden floaters, flashes, a curtain, or rapid vision loss, seek emergency care immediately.
Common questions in this guide
How often should I have eye exams for degenerative myopia?
How can I check for changes at home?
What is the risk of developing mCNV in my other eye?
Why can glaucoma be difficult to diagnose with degenerative myopia?
What vision changes require urgent care?
What support is available if degenerative myopia affects daily activities?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given that I have structural changes in one eye, what is the specific risk for my 'fellow eye' based on its current findings?
- 2.Is my optic nerve 'tilted' or 'rotated,' and how does that affect the accuracy of the glaucoma scans (OCT) we are performing?
- 3.How often should we be doing a visual field test to monitor my central vision or screen for glaucoma?
- 4.Can we establish a specific 'monitoring frequency' for my dilated exams and OCT scans based on my current stability?
- 5.If my intraocular pressure (IOP) is technically in the 'normal' range, are we still monitoring for 'normal-tension' glaucoma given my myopia?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management.
Cheung CMG, Arnold JJ, Holz FG, et al.
Ophthalmology 2017; (124(11)):1690-1711 doi:10.1016/j.ophtha.2017.04.028.
PMID: 28655539 - 2
Lacquer cracks in pathological myopia: a clinical review.
Neelam K, Ng SMS, Ho EL, Au Eong KG
Eye (London, England) 2024; (38(15)):2859-2873 doi:10.1038/s41433-024-03183-1.
PMID: 39117703 - 3
Clinical characteristics and treatment outcomes of bilateral myopic macular neovascularization in high myopic patients.
Lim SH, Bae K, Yoon CK, et al.
Acta ophthalmologica 2025; (103(8)):1049-1057 doi:10.1111/aos.17568.
PMID: 40762504 - 4
Glaucoma and Myopia: Diagnostic Challenges.
Sun MT, Tran M, Singh K, et al.
Biomolecules 2023; (13(3)) doi:10.3390/biom13030562.
PMID: 36979497 - 5
Bruch Membrane Opening Detection Accuracy in Healthy Eyes and Eyes With Glaucoma With and Without Axial High Myopia in an American and Korean Cohort.
Rezapour J, Proudfoot JA, Bowd C, et al.
American journal of ophthalmology 2022; (237()):221-234 doi:10.1016/j.ajo.2021.11.030.
PMID: 34902327 - 6
Myopic and Glaucomatous Optic Neuropathy in Highly Myopic Eyes: A Practical Framework for Diagnosis, Monitoring, and Management.
Akada M, Numa S, Tsujikawa A
Journal of clinical medicine 2026; (15(7)) doi:10.3390/jcm15072491.
PMID: 41976792 - 7
Ganglion cell-inner plexiform layer and retinal nerve fiber layer thickness according to myopia and optic disc area: a quantitative and three-dimensional analysis.
Seo S, Lee CE, Jeong JH, et al.
BMC ophthalmology 2017; (17(1)):22 doi:10.1186/s12886-017-0419-1.
PMID: 28283025 - 8
Addressing Glaucoma in Myopic Eyes: Diagnostic and Surgical Challenges.
Vinod K, Salim S
Bioengineering (Basel, Switzerland) 2023; (10(11)) doi:10.3390/bioengineering10111260.
PMID: 38002384 - 9
Algorithm of the major and minor diagnostic criteria for active myopic choroidal neovascularization.
Milani P, Mazzola M, Cigada M, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2022; (260(9)):2847-2857 doi:10.1007/s00417-022-05599-5.
PMID: 35435447 - 10
Pathologic Myopia.
Gu SZ, Chang S
Advances in experimental medicine and biology 2025; (1467()):281-283 doi:10.1007/978-3-031-72230-1_54.
PMID: 40736856 - 11
Pathologic myopia as a concurrent condition in Pierre Robin sequence: a case report and literature review.
Liu Y, Zhang XY, Hu YY, et al.
Frontiers in medicine 2026; (13()):1762569 doi:10.3389/fmed.2026.1762569.
PMID: 41907229 - 12
Progression of Myopic Maculopathy during 18-Year Follow-up.
Fang Y, Yokoi T, Nagaoka N, et al.
Ophthalmology 2018; (125(6)):863-877 doi:10.1016/j.ophtha.2017.12.005.
PMID: 29371011 - 13
Advances of optical coherence tomography in myopia and pathologic myopia.
Ng DS, Cheung CY, Luk FO, et al.
Eye (London, England) 2016; (30(7)):901-16 doi:10.1038/eye.2016.47.
PMID: 27055674 - 14
Preoperative Parameters Associated with Vitrectomy Outcomes in Myopic Traction Maculopathy Without a Full-Thickness Macular Hole.
Lee SK, Yeo S, Chung YR, et al.
Life (Basel, Switzerland) 2026; (16(2)) doi:10.3390/life16020356.
PMID: 41752991 - 15
Managing Myopic Glaucoma-Beyond Structural Fragility and Diagnostic Challenges: Review Article.
Diniz CK, Meira MA, Gondim LA, et al.
Journal of current glaucoma practice 2026; (20(1)):20-25 doi:10.5005/jp-journals-10078-1504.
PMID: 42292676 - 16
Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia.
Du R, Xie S, Igarashi-Yokoi T, et al.
JAMA ophthalmology 2021; (139(10)):1096-1103 doi:10.1001/jamaophthalmol.2021.3303.
PMID: 34436537
This page is for informational purposes only and does not constitute medical advice. Your ophthalmologist or retina specialist should set your monitoring schedule, and sudden floaters, flashes, a curtain, or rapid vision loss require urgent care.
Get notified when new evidence is published on degenerative myopia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.